COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Partial substitution of sucrose by non-nutritive sweeteners in sour orange marmalades: effects on quality characteristics and acute postprandial glycemic response in healthy volunteers
- Antioxidant activity and polyphenol composition of Pistacia terebinthus fruit from Tessala (Western Algeria)
- Biological and functional properties of vine leaves
- Effect of virgin olive and Pistacia lentiscus oils fortified with tomato lycopene on biochemical parameters in Wistar rats
- Visualization of nutrient-related clinical practice guidelines in childhood
- Farm-to-school nutrition programs with special reference to Egypt and Morocco
- Ketogenic diet: a therapeutic alternative in pediatric refractory epilepsies
- Examination of traditional fermented food consumption and product awareness of university students in Istanbul, Turkey
- Prevalence and determinants of overweight and obesity among in-school adolescents in Harare, Zimbabwe
- Impact of care group participation on nutrition knowledge, behaviour and practices
You may also start an advanced similarity search for this article.

NAJFNR is licensed under